Filing Details
- Accession Number:
- 0001209191-23-005275
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-27 16:44:04
- Reporting Period:
- 2023-01-26
- Accepted Time:
- 2023-01-27 16:44:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1634379 | Metacrine Inc. | MTCR | Pharmaceutical Preparations (2834) | 472297384 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755422 | Michael York | C/O Metacrine, Inc. 4225 Executive Square, Suite 600 San Diego CA 92037 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-26 | 107,054 | $0.41 | 103,499 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of shares to cover tax withholding obligations associated with the vesting of the restricted stock unit award granted to the Reporting Person on February 27, 2022.
- The price reported in Column 4 is an average weighted sales price. These shares were sold in multiple transactions at prices ranging from $.4114 to$.4501, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forthabove.
Billionaire Hedge Funds
